Literature DB >> 16705549

The combination of increased ovarian volume and follicle number is associated with more severe hyperandrogenism in German women with polycystic ovary syndrome.

S Hahn1, W Bering van Halteren, S Roesler, M Schmidt, R Kimmig, S Tan, K Mann, O E Janssen.   

Abstract

The prevalence and relevance of polycystic ovaries (PCO) in German women with polycystic ovary syndrome has not been evaluated. This retrospective study included 212 PCOS patients (mean age 28 years) diagnosed by the NIH-criteria and consecutively recruited since 2003. Clinical features including anthropometric variables and the degree of hirsutism, family history, menstrual cyclicity as well as endocrine biochemical parameters were recorded. In addition, 3-h oral glucose tolerance testing for indices of insulin resistance and glucose metabolism was performed in each patient. Transvaginal ultrasound was used to detect polcystic ovaries, defined as the presence of at least one ovary > 10 ml or with at least 12 follicles of 2-9 mm diameter. In this German PCOS cohort, PCO were identified in 166 women (78%). Women with PCO (PXO+) had significantly higher LH/FSH ratios (median 2.1 vs. 1.7) and IGF-1 levels (median 182.5 vs. 160.5 ng/ml) compared to patients without PCO (PCO-). In addition, a significantly higher prevalence of acne (50% vs. 33%) and higher hirsutism scores (median 9 vs. 7) were found in PCO+ patients. Testosterone levels and the free androgen index (FAI) correlated significantly with ovarian volume and the number of ovarian follicles. Also, a subgroup of PCO+ women with a combination of increased ovarian volume and follicle number had higher testosterone levels (median 3.1 vs. 2.1 nmol/l) and FAI (median 7.6 vs. 4.5) compared to women with increased follicle count but normal volume. No differences were found in metabolic parameters or insulin resistance indices. PCO are common finding in German PCOS women. PCO appear to be associated with a more pronounced hyperandrogenemia, especially when both ovarian volume and follicle number are increased.

Entities:  

Mesh:

Year:  2006        PMID: 16705549     DOI: 10.1055/s-2006-924063

Source DB:  PubMed          Journal:  Exp Clin Endocrinol Diabetes        ISSN: 0947-7349            Impact factor:   2.949


  5 in total

1.  Gestational Diabetes Mellitus and Metabolic Disorder Among the Different Phenotypes of Polycystic Ovary Syndrome.

Authors:  Mahnaz Ashrafi; Fatemeh Sheikhan; Arezoo Arabipoor; Nicole Rouhana; Roya Hosseini; Zahra Zolfaghari
Journal:  Oman Med J       Date:  2017-05

Review 2.  Hippo signaling in the ovary and polycystic ovarian syndrome.

Authors:  Kristi Maas; Sheyla Mirabal; Alan Penzias; Paul M Sweetnam; Kevin C Eggan; Denny Sakkas
Journal:  J Assist Reprod Genet       Date:  2018-08-17       Impact factor: 3.412

3.  Patterns of ovarian morphology in polycystic ovary syndrome: a study utilising magnetic resonance imaging.

Authors:  Thomas M Barber; Christopher Alvey; Tessa Greenslade; Mark Gooding; Debbie Barber; Rachel Smith; Anne Marland; John A H Wass; Tim Child; Mark I McCarthy; Stephen Franks; Stephen J Golding
Journal:  Eur Radiol       Date:  2009-11-05       Impact factor: 5.315

4.  The prevalence of metabolic syndrome and insulin resistance according to the phenotypic subgroups of polycystic ovary syndrome in a representative sample of Iranian females.

Authors:  Ferdous Mehrabian; Behnaz Khani; Roya Kelishadi; Narges Kermani
Journal:  J Res Med Sci       Date:  2011-06       Impact factor: 1.852

5.  Polymorphic Variations in VDR Gene in Saudi Women with and Without Polycystic Ovary Syndrome (PCOS) and Significant Influence of Seven Polymorphic Sites on Anthropometric and Hormonal Parameters.

Authors:  Arwa Al Thomali; Maha H Daghestani; Mazin H Daghestani; Namik Kaya; Arjumand Warsy
Journal:  J Med Biochem       Date:  2018-12-01       Impact factor: 3.402

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.